Pharmaceutical manufacturing, therapeutic molecules, and quality control services in India.
Annual revenue $2.0M Latest available
Total funding - Funding intelligence
Employees 16 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Kentreck

Kentreck is a company based in India. The company has 16 employees as of March 17, 2025. Kentreck offers products and services including Oral Antibiotics and Analgesic and Anti-Inflammatory Drugs.

Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $2.02 M (USD)
    13.54
    as on Mar 31, 2024
  • Net Profit
    $4.07 K (USD)
    13.73
    as on Mar 31, 2024
  • EBITDA
    $177.04 K (USD)
    447.9
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    16

    as on Mar 17, 2025

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Kentreck

Kentreck offers a comprehensive portfolio of products and services, including Oral Antibiotics and Analgesic and Anti-Inflammatory Drugs.

Product name locked
Category locked
Primary

Oral antibiotics are manufactured and marketed for therapeutic uses across various categories.

Product name locked
Category locked
Locked

Analgesic and anti-inflammatory drugs are produced and distributed as part of the therapeutic molecules portfolio.

Funding Insights of Kentreck

Premium access

Detailed funding history for Kentreck

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Kentreck

Investments
Premium access

Investment portfolio details for Kentreck

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Kentreck

Premium access

Detailed financials for Kentreck

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Kentreck Comparisons

Kentreck Primary company
Description
Pharmaceutical manufacturing, therapeutic molecules, and qua...
Location
India
Founded Year
-
Annual Revenue
$2.02 M (USD)
Net Profit
$4.07 K (USD)
EBITDA
$177.04 K (USD)
Employees
16
As of 2025
Premium access

Peer comparison for Kentreck

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Kentreck

Premium access

Detailed competitors of Kentreck

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Kentreck

Premium access

Complete news archive for Kentreck

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kentreck

Kentreck is headquartered in India.

As of Mar 17, 2025, the latest employee count at Kentreck is 16.

Annual revenue of Kentreck is $2.02M as on Mar 31, 2024.

The company was established in 1989 as a Private Limited entity under the companys act, operating as a fully-integrated pharmaceutical manufacturer based in Ahmedabad, Gujarat, India. It is committed to addressing global healthcare needs by producing safe, effective, and affordable medicines through the manufacturing and marketing of therapeutic molecules across multiple categories. A vision for global presence is pursued, supported by a professional team focused on transparency in finance, manufacturing, and regulatory aspects. State-of-the-art facilities and stringent quality controls are maintained to ensure product responsibility throughout the lifecycle, from development to packaging.

Kentreck offers Oral Antibiotics and Analgesic and Anti-Inflammatory Drugs.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available